Floatz logo

(S)-5-BENZYL-N-(7,9-DIFLUORO-2-OXO-2,3,4,5-TETRAHYDRO-1HBENZO(B)AZEPIN-3-YL)-1H-1,2,4-TRIAZOLE-3-CARBOXAMIDE (7,7-DIMETHYL-2- OXOBICYCLO(2.2.1)HEPTAN-1-YL)

Neoplasms, Pancreatic

GlaxoSmithKlineSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

330 Active assets in the Neoplasms, Pancreatic cohort.

Asset / SponsorPhaseRating
IMMUNOGLOBULIN G1, ANTI-(HUMANIZED MOUSE MONOCLONAL HR3 .BETA.1 CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL HR3 .KAPPA.-CHAIN, DIMER
Chinese PLA General Hospital
Phase 4BBB
Metformin
State University of New York - Downstate Medical Center
Phase 2BBB
FLUOROURACILUM
Jonsson Comprehensive Cancer Center
Phase 4BBB
S-1
Liu Xiufeng
Phase 4BB
Eloxatin
Jonsson Comprehensive Cancer Center
Phase 4BB

View all 50 →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →